Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Overall Survival in Alcyone
暂无分享，去创建一个
Andre H Crepaldi | M. Dimopoulos | A. Jakubowiak | Sung-Soo Yoon | G. Iosava | J. San-Miguel | J. Bladé | C. Doyen | S. Knop | A. Liberati | M. Mateos | T. Shelekhova | M. Cavo | Kenshi Suzuki | J. Ukropec | Z. Nagy | M. Garg | Jianping Wang | Maria I Krevvata | T. Fujisaki | L. Pour | S. Grosicki | R. Kobos | M. Cook | M. Krevvata | A. Crepaldi | P. Campbell | P. Lúcio | S. Wroblewski | Anupa Kudva